Email Updates

Search form

You are here

AVAC's Blog: P-Values

  • As in-country planning for the Key Population Investment Fund (KPIF), a PEPFAR initiative to fund programs and organizations focused on key populations, key populations (KP) groups should take center stage in the process. Leaving them behind or out of the process would mean proceeding against their will.

    July 3, 2019
    General
    Maureen Luba Milambe
  • In 2016, the Key Population Investment Fund (KPIF) was announced by PEPFAR leader Ambassador Deborah Birx at the UN High-Level Meeting. It took two years before this commitment materialized, and at the AIDS 2018 conference in Amsterdam, Ambassador Birx announced that the funds would finally be disbursed to selected awardees through PEPFAR agencies to existing cooperative agreements. The $100M (split between CDC and USAID) is meant to support scale-up of key population-led community approaches to expand and enhance HIV services. In Uganda, the $10m envelope of funding for KPIF is being implemented by CDC through existing implementing partners like The AIDS Support Organization (TASO) and Baylor.

    July 3, 2019
    General
    Kenneth Mwehonge
  • In-country planning for the Key Population Investment Fund (KPIF), a PEPFAR initiative to fund programs and organizations focused on key populations, has finally begun. AVAC and a number of our partners have been working with KP-led organizations in KPIF countries to help them engage in and influence the ongoing country-level processes. AVAC has developed a new resource and documented some of its work to-date to help inform ongoing advocacy and action. Read on for more!

    July 3, 2019
    General
    AVAC
  • In the days since the leaders of the ECHO Study announced their findings, AVAC has produced a number of resources to inform advocacy and action. These resources include a new episode of Px Pulse, a webinar, What do the ECHO Study results mean for African women? and a new document, Understanding the Results of the ECHO Study.

    June 28, 2019
    AVAC
  • Please join women and our allies for a global webinar, Thursday, June 27, 9-10am EDT / 3-4pm SAST / 4-5pm EAT, on shaping the post-ECHO agenda for comprehensive sexuality and reproductive health and rights. This emerging agenda will inform an upcoming WHO meeting on this critical subject.

    June 24, 2019
    AVAC
  • This diverse set of some of the latest resources on PrEPWatch.org will help program implementers from a variety of contexts plan for the rollout and scale-up of PrEP.

    June 18, 2019
    Jeanne Baron
  • At a satellite symposium at the South African AIDS Conference linked to a publication in The Lancet, the ECHO trial of contraceptive use and impact on HIV risk released its results. The topline finding: There was no substantial difference in HIV risk among women using DMPA-IM, the LNG implant or the copper IUD.

    June 13, 2019
    AVAC
  • The results of the ECHO Study (Evidence for Contraceptive Options in HIV Outcomes)—a trial designed look at whether three specific contraceptive methods (DMPA-IM, the Jadelle Implant and the Copper IUD) impact women’s HIV risk—will be announced on Thursday, June 13, 14:00–15:30 (South Africa Time) at the South Africa AIDS Conference in Durban.

    June 7, 2019
    AVAC
  • First, the HIV Prevention Market Manager project will present findings from research on what encourages or discourages the effective use of HIV prevention among adolescent girls and young women. And join us to discuss "vaccine hesitancy" and its implications across global health.

    May 20, 2019
    HIV Vaccine, General
    AVAC
  • This HIV Vaccine Awareness Day, Mitchell Warren talks about this promising and perilous time for vaccines. AVAC has an updated toolkit of resources for translating HIV vaccine research with a renewed sense of urgency. And we invite you to join our vaccine focused webinars.

    May 17, 2019
    Mitchell Warren

Pages